Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Hnrnpc and m 6 a RNA Methylation Control Oncogenic Transcription and Metabolism in T-Cell Leukemia

Jonas De Kesel, Igor Fijalkowski, Tim Pieters, Cristina Borin, Marino Caruso, Wouter Sleeckx, Giulia Veltri, Nitesh Devinarayan Sharma, Kim De Keersmaecker, Steven Goossens, Tom Taghon, Valentina Serafin, Bruno Palhais, Ksenia Matlawska-Wasowska, Ana Milovanovic, Eva Maria Novoa, Eric Wang, Panagiotis Ntziachristos

Blood (2024) 144 (Supplement 1): 204.

https://doi.org/10.1182/blood-2024-201475

Published: 2024

Journal Articles

A Dual Role of SOX11 Expression in the Formation of T-Cell Acute Lymphoblastic Leukemia in Mouse Models

André De Almeida, Sara T'Sas, Els Van Ammel, Pieter Van Vlierberghe, Tim Pieters, Steven Goossens

Blood (2023) 142 (Supplement 1): 1406.

https://doi.org/10.1182/blood-2023-179584

Published: 2023

Journal Articles

PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia

Stien De Coninck, Renate De Smedt, Beatrice Lintermans, Steven Goossens, Pieter Van Vlierberghe

Blood (2022) 140 (Supplement 1): 11513–11514.

https://doi.org/10.1182/blood-2022-168556

Published: 2022

Journal Articles

SOX11 Functions As an Oncogene in Lmo2-Driven T-Cell Lymphoblastic Leukemia (T-ALL)

André De Almeida, Tim Pieters, Sara T'Sas, Steven Goossens, Pieter Van Vlierberghe

Blood (2021) 138 (Supplement 1): 1136.

https://doi.org/10.1182/blood-2021-149471

Published: 2021

Journal Articles

Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-Cell Acute Lymphoblastic Leukemia

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-138501

Published: 2020

Journal Articles

The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1

Blood (2020) 136 (8): 957–973.

https://doi.org/10.1182/blood.2019002548

Published: 2020

Includes: Supplemental data

Journal Articles

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

Blood (2020) 135 (19): 1685–1695.

https://doi.org/10.1182/blood.2019003880

Published: 2020

Includes: Supplemental data

Journal Articles

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

Steven Goossens, PhD, Jueqiong Wang, PhD, Cedric Tremblay, PhD, Pieter Van Vlierberghe, PhD, Geert Berx, PhD, Tom Taghon, PhD, Jody J Haigh, PhD

Blood (2018) 132 (Supplement 1): 3916.

https://doi.org/10.1182/blood-2018-99-111104

Published: 2018

Journal Articles

LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis

Sara El Ashkar, Juerg Schwaller, Tim Pieters, Steven Goossens, Jonas Demeulemeester, Frauke Christ, Siska Van Belle, Sabine Juge, Nancy Boeckx, Alan Engelman, Pieter Van Vlierberghe, Zeger Debyser, Jan De Rijck

Blood (2018) 131 (1): 95–107.

https://doi.org/10.1182/blood-2017-05-786962

Published: 2018

Includes: Supplemental data

Journal Articles

Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Renate De Smedt, MSc, Sofie Peirs, PhD, Julie Morscio, PhD, Juliette Roels, MSc, Steven Goossens, PhD, Aurore Touzart, MD, Anne Uyttebroeck, Nadine Van Roy, PhD, Tim Lammens, PhD, Lara Mussolin, PhD, Elizabeth Macyntire, MD PhD, Peter Vandenberghe, MD PhD, Pieter Van Vlierberghe, PhD

Blood (2017) 130 (Supplement 1): 1445.

https://doi.org/10.1182/blood.V130.Suppl_1.1445.1445

Published: 2017

Journal Articles

Novel oncogenic noncoding mutations in T-ALL

Steven Goossens, Pieter Van Vlierberghe

Blood (2017) 129 (24): 3140–3142.

https://doi.org/10.1182/blood-2017-04-773242

Published: 2017

Journal Articles

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia

Steven Goossens, Sofie Peirs, Wouter Van Loocke, Jueqiong Wang, Mina Takawy, Filip Matthijssens, Stefan E. Sonderegger, Katharina Haigh, Thao Nguyen, Niels Vandamme, Magdaline Costa, Catherine Carmichael, Filip Van Nieuwerburgh, Dieter Deforce, Oded Kleifeld, David J. Curtis, Geert Berx, Pieter Van Vlierberghe, Jody J. Haigh

Blood (2017) 129 (8): 981–990.

https://doi.org/10.1182/blood-2016-06-721191

Published: 2017

Includes: Supplemental data

Journal Articles

The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling

Blood (2017) 129 (4): 460–472.

https://doi.org/10.1182/blood-2016-05-714659

Published: 2017

Includes: Supplemental data

Journal Articles

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Tim Pieters, PhD, Steven Goossens, PhD, Sara T'Sas, Geert Berx, PhD, Jody J. Haigh, PhD, Pieter Van Vlierberghe, Prof

Blood (2016) 128 (22): 1748.

https://doi.org/10.1182/blood.V128.22.1748.1748

Published: 2016

Journal Articles

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

Steven Goossens, PhD, Sofie Peirs, MSc, Geert Berx, PhD, Pieter Van Vlierberghe, PhD, Jody J. Haigh, PhD

Blood (2016) 128 (22): 4027.

https://doi.org/10.1182/blood.V128.22.4027.4027

Published: 2016

Journal Articles

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

Catherine L Carmichael, PhD, Steven Goossens, PhD, Jueqiong Wang, PhD, Thao Nguyen, PhD, Katharina Haigh, Geert Berx, PhD, Benjamin Kile, PhD, Jody J Haigh, PhD

Blood (2016) 128 (22): 2688.

https://doi.org/10.1182/blood.V128.22.2688.2688

Published: 2016

Journal Articles

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Blood (2014) 124 (25): 3738–3747.

https://doi.org/10.1182/blood-2014-05-574566

Published: 2014

Includes: Supplemental data

Journal Articles

Zeb2-Defficiency in the Adult Murine Hematopoietic Precursor Cells Leads to Differentiation Defects in Multiple Hematopoietic Lineages and a Myeloproliferative-Like Phenotype

Tamara Riedt, Steven Goossens, PhD, Ines Gütgemann, MD, Carmen Carrillo-Garcia, PhD, Hichem D Gallala, PhD, Holger Fröhlich, PhD, Peter Brossart, MD, Dany Huylebroeck, PhD, Jody J Haigh, PhD, Viktor Janzen, MD

Blood (2012) 120 (21): 1199.

https://doi.org/10.1182/blood.V120.21.1199.1199

Published: 2012

Journal Articles

The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization

Steven Goossens, Viktor Janzen, Sonia Bartunkova, Tomomasa Yokomizo, Benjamin Drogat, Mihaela Crisan, Katharina Haigh, Eve Seuntjens, Lieve Umans, Tamara Riedt, Pieter Bogaert, Lieven Haenebalcke, Geert Berx, Elaine Dzierzak, Danny Huylebroeck, Jody J. Haigh

Blood (2011) 117 (21): 5620–5630.

https://doi.org/10.1182/blood-2010-08-300236

Published: 2011

Includes: Supplemental data

Journal Articles

Vegf regulates embryonic erythroid development through Gata1 modulation

Benjamin Drogat, Joanna Kalucka, Laura Gutiérrez, Hamida Hammad, Steven Goossens, Morvarid Farhang Ghahremani, Sonia Bartunkova, Katharina Haigh, Kim Deswarte, Omar Nyabi, Michael Naessens, Napoleone Ferrara, Ursula Klingmüller, Bart N. Lambrecht, Andras Nagy, Sjaak Philipsen, Jody J. Haigh

Blood (2010) 116 (12): 2141–2151.

https://doi.org/10.1182/blood-2010-01-264143

Published: 2010

Includes: Supplemental data

NARROW

Hnrnpc and m 6 a RNA Methylation Control Oncogenic Transcription and Metabolism in T-Cell Leukemia

A Dual Role of SOX11 Expression in the Formation of T-Cell Acute Lymphoblastic Leukemia in Mouse Models

PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia

SOX11 Functions As an Oncogene in Lmo2-Driven T-Cell Lymphoblastic Leukemia (T-ALL)

Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-Cell Acute Lymphoblastic Leukemia

The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1

Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis

Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Novel oncogenic noncoding mutations in T-ALL

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia

The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Zeb2-Defficiency in the Adult Murine Hematopoietic Precursor Cells Leads to Differentiation Defects in Multiple Hematopoietic Lineages and a Myeloproliferative-Like Phenotype

The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization

Vegf regulates embryonic erythroid development through Gata1 modulation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only